Clinical Trial Update: Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating sargramostim for metastatic renal cell carcinoma with lung metastases has been completed. The provided snippet does not include trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma Metastatic

Drugs mentioned

• sargramostim (sargramostim)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Kidney Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED